[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sacroiliac-joint-dysfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sacroiliac-joint-dysfunction":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,16,0,[8,47,71,105,133,154,182,208,234,262,281,306,330,351,376,397],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100636427","posterior-inferior-intra-articular-cortical-piercing-titanium-implant-for-sacroiliac-joint-fusion-evaluation-of-safety-and-effectiveness-outcomes-100636427",false,"NCT07565545","Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes","Posterior-Inferior Intra-articular Cortical PiERcing Titanium Implant for SaCroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes","PIERCE","Inclusion Criteria:\n\n1. Age \\> 21 years.\n2. Patient has chronic lower back pain (≥6 months) refractory to non-surgical care.\n3. Diagnosis of sacroiliac joint dysfunction (degenerative sacroiliitis or SIJ disruption) and scheduled to be treated with INTRA Ti.\n4. Patient has SIJ pain of at least 5 on a 0-10 numeric rating scale (NRS) prior to procedure.\n5. Participant has signed study-specific informed consent form.\n\nExclusion Criteria:\n\n1. ASA score 4 or 5.\n2. Severe back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, and lumbar vertebral body fracture.\n3. Other known sacroiliac pathology such as: inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA-associated spondyloarthropathy), tumor, infection, acute fracture.\n4. Current diagnosis of cluneal neuralgia.\n5. Previous SIJ implant placement, including allograft, on the treated (index) side.\n6. Anatomic anomalies\u002Fdefects that would preclude safe and\u002For biomechanically acceptable device placement.\n7. History of recent (\\\u003C1 year) major trauma to pelvis.\n8. Previously diagnosed or suspected severe osteoporosis (defined as prior T-score \\\u003C -2.5 or history of osteoporotic fracture).\n9. Chronic rheumatologic condition (e.g., rheumatoid arthritis).\n10. Current diagnosis of fibromyalgia.\n11. Known allergy to titanium or titanium alloys.\n12. Current local or systemic infection that raises the risk of surgery.\n13. Patient currently receiving or seeking worker's compensation, disability remuneration, and\u002For involved in injury litigation.\n14. Currently pregnant or planning pregnancy in the next 2 years (self-reported).\n15. Patient is a prisoner or a ward of the state.\n16. Known or suspected active drug or alcohol abuse, including opioids\n17. Diagnosed psychiatric disease (e.g., schizophrenia, major depression, personality disorders) that could interfere with study participation.","ALL","21 Years",{"count":20,"type":21},120,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate outcomes in patients treated with iFuse INTRA Ti for chronic SI joint pain.",[25,26,27,28,29,30],"Sacro Iliac Joint Pain","Sacro-iliac Joints","Sacroiliac Disorder","Sacroiliac Joint Dysfunction","Sacroiliac Joint Disruption","Degenerative Sacroiliitis",[32,33,34],"sacroiliac fusion","SI-BONE","INTRA Ti","NOT_YET_RECRUITING","2026-06-17",{"date":38,"type":39},"2026-06-22","ACTUAL",{"date":41,"type":21},"2026-09",{"date":43,"type":21},"2029-09",{"name":45,"class":46},"SI-BONE, Inc.","INDUSTRY",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":70},"100635017","post-market-clinical-study-using-traq-for-minimally-invasive-posterior-sacroiliac-joint-fusion-100635017","NCT07547215","Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion","An Open Label, Prospective, Multicenter, Single-Arm, Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion","TRAQTION","Inclusion Criteria:\n\nTo be eligible to participate in this study, a subject must meet all the following criteria, as determined by the Investigator:\n\n1. Age and Body Mass Index (BMI)\n\n   1. Adult patients aged ≥ 21 years at screening.\n   2. BMI ≤ 40.\n2. Chronic SIJ Related Pain\n\n   1. Has experienced low back and\u002For buttock pain for at least 6 months that has been inadequately responsive to non surgical management.\n   2. Has experienced nonradicular pain that is maximal below the L5 vertebrae, localized over the posterior SIJ, and consistent with SIJ pain.\n3. Diagnosis of SIJ Dysfunction\n\n   a. Has a diagnosis of SIJ dysfunction (degenerative sacroiliitis or SIJ disruption) based on ALL of the following: i. A positive Fortin's finger test; and ii. Pain elicited on at least three (3) of five (5) SIJ specific physical examination maneuvers (FABER test, Gaenslen's test, Distraction, Thigh Thrust, Compression); and iii. At least 75% reduction in pain, with associated improvement in previously painful maneuvers, for the expected duration of action following two (2) image guided, contrast enhanced intra articular diagnostic SIJ injections, performed on separate visits using anesthetics with different durations of action; and iv. Completion of at least one (1) therapeutic intra articular SIJ injection (e.g., corticosteroid injection) within the past 12 months.\n4. Baseline Disability and Pain Severity\n\n   a. Baseline Oswestry Disability Index (ODI) score ≥30%; and b. Baseline SI joint pain score of ≥60 mm on a 100 mm Visual Analog Scale (VAS).\n5. Treatment Decision a. The treating physician has independently determined that the TRAQ procedure is an appropriate treatment option for the subject's SIJ dysfunction in the course of routine clinical care, and the subject has agreed to undergo this treatment.\n6. Informed Consent and Compliance\n\n   1. Is willing and capable of providing written informed consent; and\n   2. Is willing and able to comply with all study related requirements, procedures, and follow up visits.\n\nExclusion Criteria:\n\nSubjects must meet none of the following criteria to be eligible for participation in this study, as determined by the Investigator:\n\n1. Pain Source Uncertainty\n\n   a. Inability to confirm, in the Investigator's clinical judgment, that the subject's primary pain generator is the sacroiliac joint.\n2. Alternative Primary Spine Pathology\n\n   a. Presence of severe low back pain attributable to other spinal pathology, including but not limited to lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, or lumbar vertebral body fracture.\n3. Other Sacroiliac Pathology a. Presence of known sacroiliac joint pathology other than degenerative SIJ dysfunction, including inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA associated spondyloarthropathies), tumor, infection, acute fracture, or crystal arthropathy.\n4. Non SIJ Pain Syndromes\n\n   a. History of coccydynia or prior coccygectomy, endometriosis, cluneal neuralgia, or pudendal neuralgia.\n5. Recent Sacral Interventions\n\n   a. Prior sacral radiofrequency ablation performed within 6 months prior to enrollment.\n6. Recent Pelvic Trauma\n\n   a. History of major pelvic trauma within 12 months prior to enrollment.\n7. Severe Osteoporosis\n\n   a. Prior diagnosis or suspicion of severe osteoporosis, defined as a prior bone mineral density T score of \\\u003C -2.5 or a history of osteoporotic fracture.\n8. Medications Affecting Bone or Soft Tissue Healing\n\n   a. Current use of medications known to adversely affect bone quality or soft tissue healing, as determined by the Investigator.\n9. Anatomic Constraints\n\n   a. Anatomic anomalies or defects that, in the Investigator's opinion, would preclude safe or biomechanically appropriate device placement.\n10. Systemic Inflammatory or Rheumatologic Disease\n\n    a. Presence of a chronic inflammatory rheumatologic condition, such as rheumatoid arthritis.\n11. Centralized Pain Syndromes\n\n    a. Current diagnosis of fibromyalgia.\n12. Infection Risk\n\n    a. Evidence of current local or systemic infection that would increase surgical risk.\n13. High-Dose Opioid Therapy (≥90 MME\u002Fday)\n\n    a. Current use of systemic opioid analgesics at Screening\u002FBaseline with an average daily dose ≥90 morphine milligram equivalents (MME\u002Fday), based on medication reconciliation (prescription records and subject report) and standard MME conversion factors.\n14. Current Nicotine Use (Self-Reported)\n\n    a. Self-reported use of any nicotine-containing products (including smoking, vaping\u002Fe-cigarettes, cigars, pipes, smokeless tobacco, nicotine pouches, and nicotine replacement products) within 6 weeks prior to Screening\u002FBaseline.\n15. Secondary Gain or Litigation\n\n    a. Currently receiving or actively seeking workers' compensation or disability benefits or involved in injury related litigation.\n16. Pregnancy\n\n    a. Currently pregnant or planning to become pregnant within two (2) years following enrollment, as self reported.\n17. Vulnerable Populations\n\n    a. Individuals who are prisoners or wards of the state.\n18. Substance Abuse\n\n    a. Known or suspected active drug or alcohol abuse, including opioid misuse.\n19. Psychiatric Conditions\n\n    a. Diagnosed psychiatric disorder (e.g., schizophrenia, major depressive disorder, personality disorder) that, in the Investigator's judgment, could interfere with study participation.\n20. Concurrent Interventional Research\n\n    a. Current participation in another clinical trial.\n21. Neurologic Conditions Affecting Rehabilitation\n\n    a. Presence of a significant neurologic disorder that would interfere with participation in physical therapy or post procedural rehabilitation.\n22. Other Confounding Medical Conditions a. Any other medical condition or pain condition not intended to be treated in this study that, in the Investigator's judgment, could interfere with study procedures, accurate pain reporting, or interpretation of study endpoints.",{"count":56,"type":21},100,"The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.",[28,59],"Sacroiliac Joint Pain","RECRUITING","2026-06-11",{"date":63,"type":39},"2026-06-15",{"date":65,"type":39},"2026-05-27",{"date":67,"type":21},"2028-12",{"name":69,"class":46},"PainTEQ, LLC",1,{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":78,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":4,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":89,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":70},"100626839","effects-of-core-stability-and-pelvic-clock-exercises-in-sacroiliac-joint-dysfunction-100626839","NCT07440849","Effects of Core Stability and Pelvic Clock Exercises in Sacroiliac Joint Dysfunction","Combine Effects of Core Stability and Pelvic Clock Exercises on Pain, Disability and Quality of Life in Postpartum Females With Sacroiliac Joint Dysfunction","Inclusion Criteria:\n\n* Vaginal delivery\n* Primiparous women\n* Pain intensity greater than 6 on the Numerical Pain Rating Scale (NPRS)\n* Positive responses to at least three physical provocation tests suggestive of sacroiliac joint dysfunction\n\nExclusion Criteria:\n\n* Participants were excluded from the study if they had any of the following conditions:\n* Previous history of trauma\n* Musculoskeletal disorders (e.g., coccydynia, impingement syndrome)\n* Postpartum depression\n* Disc bulge or degeneration",true,"FEMALE","25 Years","35 Years",{"count":83,"type":21},50,"INTERVENTIONAL",[86],"NA","The study will be a randomized control trial and will be conducted in DHQ and Sadiq Hospital in Sargodha District. This study will be completed in time duration of 10 months after the approval of synopsis. Nonprobability convenience sampling technique will be used and 50 participants will be recruited in study after randomization. The subjects will be divided into two groups. Group A(Experimental) will receive core stability and pelvic clock exercises with baseline treatment while Group B(Control) will receive only core stability exercises after baseline treatment. The tools that will be used are Numeric Pain Rating Scale (NPRS), Oswestry Disability index (ODI) and WHOQOL-BREF. Treatment have duration of 8 weeks with 3 sessions per week and an hour per session is requires. After data collection, data will be analyzed by using SPSS version 26.",[28],[28,90,91,92,93,94],"Core Stability Exercises,","Pelvic Clock Exercise,","Postpartum Pain,","Disability,","Quality of Life","2026-06-08",{"date":97,"type":39},"2026-06-10",{"date":99,"type":39},"2024-12-01",{"date":101,"type":21},"2026-08-01",{"name":103,"class":104},"Riphah International University","OTHER",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":109,"acronym":110,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":17,"minAge":112,"maxAge":113,"enrollmentInfo":114,"targetDuration":4,"studyType":84,"phases":116,"briefSummary":117,"conditions":118,"keywords":119,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":132},"100633623","combined-effects-of-mulligans-mobilization-with-movement-and-kinetic-control-training-on-pain-range-of-motion-gait-and-functional-disability-among-patients-with-sacroiliac-joint-dysfunction-100633623","NCT07529093","Combined Effects of Mulligan's Mobilization With Movement and Kinetic Control Training on Pain, Range of Motion, Gait and Functional Disability Among Patients With Sacroiliac Joint Dysfunction","MWM KCT SIJD","Inclusion Criteria:\n\n* Both male and female patients\n* Age between 45- 64 years\n* Unilateral non-radiating pain\n* Confirmed diagnosis through at least 3\u002F5 provocative tests Faber test Distraction test Thigh thrust test Gaenslen test Sacral thrust test\n* Pain rating from 4-6 on Numeric Pain Rating Scale\n* Symptoms of SIJD for more than 2 months\n\nExclusion Criteria:\n\n* Patients with history of any surgery at lumbo-sacral or pelvic region\n* Pregnancy, lactation\n* Congenital, postural deformities\n* Acute disc hernia and spinal stenosis that may cause pain in the lower back and hips, piriformis syndrome\n* Rheumatic diseases (fibromyalgia, ankylosing spondylitis, rheumatic arthritis)\n* Acute infections or malignancies\n* Having received manual therapy for the sacroiliac joint in the past 3 months\n* Injection of corticosteroids or anesthesia in the SIJ during the previous 1 month\n* Psychological disorders affecting the subject's ability to follow the instructions","45 Years","64 Years",{"count":115,"type":21},55,[86],"Sacroiliac joint dysfunction (SIJD) is a frequent source of low back and pelvic pain and contributes significantly to movement restriction, altered gait patterns, and functional disability in adults. It is associated with impaired lumbopelvic motor control, weakness of key stabilizing muscles, and faulty load transfer across the pelvis. SIJD is prevalent in both physically active individuals and sedentary populations. In addition to its clinical impact, SIJD imposes a considerable socioeconomic burden due to reduced work productivity and long-term disability.\n\nContemporary management of SIJD emphasises on pain reduction, restoration of movement, functional independence, and participation in daily activities. Manual therapy techniques such as Mulligan's Mobilization with Movement (MWM) are widely used to correct positional faults and restore pain-free movement, while kinetic control training targets deficits in motor control of the lumbopelvic stabilizing muscles. Although both approaches are individually supported in the literature, evidence regarding their combined effectiveness on pain, range of motion, gait parameters, and functional disability remains limited. Therefore, this study aims to compare the effects of combined Mulligan's Mobilization with Movement and kinetic control training versus kinetic control training alone in patients with sacroiliac joint dysfunction using validated outcome measures.",[28],[28,120,121,122],"Mulligan's Mobilization with Movement","Kinetic Control Training","Uncontrolled Movement","2026-05-21",{"date":125,"type":39},"2026-05-26",{"date":127,"type":39},"2026-04-15",{"date":129,"type":21},"2026-10-15",{"name":131,"class":104},"Lahore University of Biological and Applied Sciences",2,{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":137,"acronym":4,"eligibilityCriteria":138,"healthyVolunteers":11,"sex":17,"minAge":80,"maxAge":112,"enrollmentInfo":139,"targetDuration":4,"studyType":84,"phases":141,"briefSummary":142,"conditions":143,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":70},"100639395","comparative-effects-of-autogenic-inhibition-and-reciprocal-inhibition-technique-on-pain-functional-disability-and-gait-in-sacroiliac-joint-dysfuction-100639395","NCT07600359","Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.","Inclusion Criteria:\n\n* Patients having low back pain greater than 4 weeks\n* Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.\n* Patients not having any other condition that can affect gait\n* 25-45 years\n* Both males and females\n\nExclusion Criteria:\n\n* Patients having nonspecific low back\n* Patients with lumbosacral fusion\n* Patients with any neurological condition\n* Patients with history of trauma of spine\n* Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)\n* Patients with any hip joint pathology\n* Patients using any assistive device",{"count":140,"type":21},40,[86],"Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. However, SI joint dysfunction is one of the most common causes of low back pain among the patients suffering from non-radicular low back pain. There can be a mechanical source which is due to muscle insufficiency or instability or a non-mechanical source which is osteoarthritis, infection or any trauma. It is thought to affect females more commonly with prevalence of about 46.71% in females and with the prevalence of about 15 to 30% in general. This poses great threat to bio mechanics of the body which can significantly lead to disability that can affect mobility, daily activities and quality of life of the individual. According to a study the pain caused by SIJD caused activity limitation and participation restriction of about 25% of the individuals. Hence making it difficult for them to continue their jobs. increased pain leads to worsening of the ability to perform ADLs which ultimately effects the quality of life. Altered biomechanics also leads to alteration in spatio temporal gait parameters.This study aims to compare the effects of autogenic inhibition technique and reciprocal inhibition technique in addition with conventional therapy in reliving low back pain, improving functional disability and alteration in spatio-temporal gait parameters in patients with sacroiliac joint dysfunction. Patients with SIJD will be recruited and will be randomly divided into two groups 20 in each group. Group 1 will receive autogenic inhibition technique of iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises and group 2 will receive reciprocal inhibition technique on iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises. The treatment will be continued for 3 weeks with 4 sessions of 25 minutes per week.",[28,144],"Muscle Energy Techniques","2026-05-14",{"date":147,"type":39},"2026-05-20",{"date":149,"type":21},"2026-05-15",{"date":151,"type":21},"2026-07-15",{"name":153,"class":104},"Foundation University Islamabad",{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":159,"acronym":4,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":17,"minAge":161,"maxAge":162,"enrollmentInfo":163,"targetDuration":4,"studyType":84,"phases":165,"briefSummary":166,"conditions":167,"keywords":168,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":173,"lastUpdatePostDateStruct":174,"startDateStruct":176,"completionDateStruct":178,"leadSponsor":180,"locationsCount":70},"100635303","efficacy-of-dry-needling-for-releasing-the-sacrotuberous-ligament-in-patients-with-sacroiliac-joint-dysfunctions-100635303","NCT07550933","Efficacy of Dry Needling for Releasing the Sacrotuberous Ligament in Patients With Sacroiliac Joint Dysfunctions","Efficacy of Dry Needling for Releasing the Sacrotuberous Ligament on Pain Intensity, Functional Disability, and Biomechanical Changes in Patients With Sacroiliac Joint Dysfunctions","Inclusion Criteria:\n\n* Diagnosed patients having symptoms of sacroiliac joint dysfunction\n* Both genders\n* Age 40-65 years\n* Standard clinical tests positive (Fortin finger test, Patrick's test)\n* Imaging (MRI\u002FX-ray)\n\nExclusion Criteria:\n\n* Patients with a previous history of fracture\n* Prior SIJ surgery\n* Osteoporosis\n* Pregnancy or post-partum\n* Lumbar disc herniation\n* Carcinoma\n* Dislocation in the lower back and lower extremity\n* Spinal stenosis that may cause pain in the lower back and hips\n* Piriformis syndrome\n* Lumbar radiculopathy\n* Existence of known osteoporosis\n* Metabolic diseases\n* Severe cardiovascular disease\n* Uncontrolled hypertension\n* Severe renal diseases\n* Bilateral cases","40 Years","65 Years",{"count":164,"type":21},60,[86],"Sacroiliac joint dysfunction is a common source of low back and pelvic pain, often caused by improper load transfer through the pelvis. The sacrotuberous ligament stabilises the sacroiliac joint by limiting sacral nutation and supporting posterior pelvic structures. The sacroiliac joint connects the sacrum to the ischial tuberosity and integrates with muscles like the gluteus maximus and biceps femoris. Tightness, dysfunction, or pain in the sacrotuberous ligament can exacerbate sacroiliac joint dysfunction by altering mechanics. Dry needling is increasingly used for myofascial pain and muscle dysfunction. Applying dry needling to release ligamentous structures is novel and may improve the biomechanics of the sacroiliac joint by alleviating tension in the sacrotuberous ligament. The aim of the study is to investigate the efficacy of dry needling for releasing the sacrotuberous ligament in patients with sacroiliac joint dysfunctions on pain intensity, functional disability, and biomechanical changes, along with routine physical therapy compared to sham dry needling and routine physical therapy.",[28],[169,170,171,172],"Sacroiliac joint dysfunction","dry needling","physical therapy","sacrotuberous ligament","2026-04-19",{"date":175,"type":39},"2026-04-24",{"date":177,"type":21},"2026-04",{"date":179,"type":21},"2026-11",{"name":181,"class":104},"University of Social Welfare and Rehabilitation Science",{"id":183,"slug":184,"hasResults":11,"nctId":185,"briefTitle":186,"officialTitle":186,"acronym":187,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":17,"minAge":189,"maxAge":4,"enrollmentInfo":190,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":191,"conditions":192,"keywords":197,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":201,"startDateStruct":203,"completionDateStruct":205,"leadSponsor":207,"locationsCount":4},"100633731","real-world-evidence-of-si-bones-ifuse-torq-tnt-advancing-treatment-of-pelvic-ring-fractures-100633731","NCT07530497","Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures","REBAR","Inclusion Criteria:\n\n1. ≥ 60 years of age at screening\n2. Pelvic pain correlating with fracture location that began EITHER within 6 weeks of a known low-energy traumatic event, OR pelvic insufficiency fracture with pain that is limiting mobility\n3. Diagnostic imaging (X-ray and CT) showing fracture of the pelvis that correlates with pain location\n4. Patient is scheduled for pelvic fixation using at least one iFuse TORQ TNT\n5. Patient and\u002For patient's legally authorized representative (LAR) understands and is willing and able to provide written informed consent\n6. Patient agrees to comply with study schedule of assessments\n7. Patient and\u002For patient's proxy can complete study-related surveys\n8. Patient was able to ambulate prior to index fracture\n\nExclusion Criteria:\n\n1. Any known anatomic issues that could prevent placement of iFuse TORQ TNT\n2. Implants already in the pelvis (e.g. lumbopelvic fixation) that could interfere with placement of the study device(s)\n3. Patient requires lumbosacral pelvic fixation as part of index procedure\n4. Prominent neurologic or uncontrolled psychiatric condition that would interfere with study participation or regaining of physical function related to pelvic fracture and is unable to provide a health care proxy to complete study assessments.\n5. Estimated lifespan \\\u003C 12 months\n6. Presence of tumor, lytic lesion, infection, or soft tissues that precludes safe internal fixation\n7. Not candidate for surgery due to underlying medical illness\n8. Social situation that makes 12-month follow-up unlikely\n9. History of recent (within 1 year) non-index pelvic fracture with non-union\n10. Other clinically active fragility fracture of spine, hip or arms\u002Flegs that could impair recovery from sacral fracture\n11. Known allergy to titanium or titanium alloys\n12. Known or suspected active drug or alcohol abuse, including opioids\n13. Patient is a prisoner or ward of the state\n14. Patient is already participating in an investigational clinical trial that may interfere with implant placement or study follow-up","60 Years",{"count":20,"type":21},"The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.",[193,194,195,196,29,28],"Fracture; Pelvic","Insufficiency Fractures","Fragility Fracture","Sacroiliac; Fusion",[195,198,199,200],"pelvic fracture","Osteoporotic pelvic fracture","Fragility Fracture of the pelvis",{"date":202,"type":39},"2026-04-20",{"date":204,"type":21},"2026-08",{"date":206,"type":21},"2028-08",{"name":45,"class":46},{"id":209,"slug":210,"hasResults":11,"nctId":211,"briefTitle":212,"officialTitle":213,"acronym":214,"eligibilityCriteria":215,"healthyVolunteers":11,"sex":17,"minAge":216,"maxAge":112,"enrollmentInfo":217,"targetDuration":4,"studyType":84,"phases":218,"briefSummary":219,"conditions":220,"keywords":221,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":226,"lastUpdatePostDateStruct":227,"startDateStruct":229,"completionDateStruct":231,"leadSponsor":233,"locationsCount":70},"100625635","comparative-effects-of-two-rehabilitation-approaches-on-lumbopelvic-function-in-sacroiliac-joint-dysfunction-100625635","NCT07425197","Comparative Effects of Two Rehabilitation Approaches on Lumbopelvic Function in Sacroiliac Joint Dysfunction","Effects of Dynamic Neuromuscular Stabilization Verses Core Stability Exercises on Pain and Lumbopelvic Stability Among Patients With Sacroiliac Joint Dysfunction","DNS CSE SIJD","Inclusion criteria\n\n1. Age between 30 and 45 years\n2. Confirmed diagnosis by at least three positive provocation tests\n\n   * FABER\n   * Gaenslen's, Thigh Thrust\n   * Compression\n   * Distraction\n3. Pain lasting three months or longer\n4. NPRS score between 4 and 7\n\nExclusion criteria:\n\n1. Other spinal conditions such as, spinal stenosis or tumors\n2. Prior history of spinal or pelvic surgery\n3. Patients with neurological disorders or systemic diseases such as rheumatoid arthritis\n4. Pregnant women\n5. Patients with cardiopulmonary conditions","30 Years",{"count":140,"type":21},[86],"This research compares two rehabilitation strategies for people with sacroiliac joint dysfunction (SIJD): Dynamic Neuromuscular Stabilization (DNS) and Core Stability Exercises (CSE). SIJD is presented as a biomechanical source of low-back, buttock and leg pain caused by altered joint mechanics, muscle control problems, or asymmetric pelvic alignment; diagnosis relies on clinical provocation tests and exclusion of other causes. The study aims to determine which of the two exercise-based approaches better reduces pain and improves lumbopelvic control. The trial is a single-blinded, parallel randomized controlled trial conducted in an outpatient physiotherapy setting with supervised sessions over four weeks. Adults aged 20-50 with at least three positive SIJ provocation tests and moderate, chronic pain were included; important exclusions were prior spinal\u002Fpelvic surgery, systemic inflammatory disease, pregnancy, cardiopulmonary limitation or poor session attendance. Each participant received a baseline conventional physiotherapy package; one arm received a DNS program (breathing-based and developmental movement patterns) and the other performed progressive core-stability training emphasizing transversus abdominis and multifidus activation. Primary outcomes are pain (Numeric Pain Rating Scale) and lumbopelvic stability measured with a pressure biofeedback unit (PBU). Data were collected at baseline and after four weeks; the analysis plan uses SPSS with paired and independent t-tests, ANCOVA to adjust for baseline differences, and effect sizes\u002Fconfidence intervals to interpret clinical relevance. Safety, informed consent, assessor blinding and standard ethical safeguards are described. The synopsis notes a gap in direct RCT evidence comparing DNS and CSE for SIJD and positions this trial to address that gap with clinical and mechanistic outcomes.",[28],[222,223,224,225],"SIJD","DNS","Core stability","lumbopelvic stability","2026-03-16",{"date":228,"type":39},"2026-03-19",{"date":230,"type":21},"2026-03-18",{"date":232,"type":21},"2026-09-27",{"name":131,"class":104},{"id":235,"slug":236,"hasResults":11,"nctId":237,"briefTitle":238,"officialTitle":239,"acronym":4,"eligibilityCriteria":240,"healthyVolunteers":11,"sex":17,"minAge":241,"maxAge":242,"enrollmentInfo":243,"targetDuration":4,"studyType":84,"phases":245,"briefSummary":246,"conditions":247,"keywords":250,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":254,"lastUpdatePostDateStruct":255,"startDateStruct":257,"completionDateStruct":259,"leadSponsor":261,"locationsCount":4},"100619534","connective-tissue-dry-needling-for-low-back-pain-related-to-local-posterior-superior-iliac-spine-pain-100619534","NCT07345871","Connective Tissue Dry Needling for Low Back Pain Related to Local Posterior Superior Iliac Spine Pain","Investigating the Effectiveness of Connective Tissue Dry Needling Technique on Patients With Low Back Pain Caused by Local Pain at Superior Posterior Iliac Spine: a Single-blind, Randomized Controlled Trial","Inclusion criteria:\n\n1. Adults aged 18 to 75 years.\n2. Diagnosed with chronic mechanical low back pain localized at the posterior superior iliac spine region.\n3. Presence of point tenderness reproducible by palpation at the posterior superior iliac spine area.\n4. Pain duration of at least two weeks, indicating the non-acute stage of low back pain.\n5. Negative results in at least three out of five sacroiliac pain provocation tests (Distraction, Compression, Thigh Thrust, Sacral Thrust, Gaenslen).\n6. Pain intensity ≥ 3 on the Numeric Rating Scale at baseline.\n7. Ability to communicate and cooperate with the research team during intervention and follow-up.\n8. Access to WhatsApp or equivalent communication application for follow-up pain reporting at the 3-month stage.\n\nNon-inclusion criteria:\n\n1. Presence of lumbar radicular pain or referred pain to the lower limbs.\n2. History of lumbar spine trauma within the previous three months.\n3. Fear or intolerance of needling procedures.\n4. Current use of anticoagulant medication.\n5. Known lymphatic disorders, immunosuppressive diseases, or neurological conditions such as epilepsy or seizure disorders.\n6. Pregnancy or suspected pregnancy.\n\nExclusion criteria:\n\n1. Voluntary withdrawal of consent at any time during the study.\n2. Inability to tolerate the intervention or adverse reaction during treatment sessions.\n3. Occurrence of serious adverse events or complications (e.g., infection, bleeding).\n4. Non-compliance with treatment protocol or missing more than two sessions.\n5. Any intercurrent illness or therapy that could interfere with the study outcomes or safety assessment","18 Years","75 Years",{"count":244,"type":21},42,[86],"This single-blind randomized controlled trial will aim to determine the effectiveness of a connective tissue dry needling (CTDN) technique, in reducing pain and improving function in individuals with chronic mechanical low back pain associated with pain and tenderness at the posterior superior iliac spine (PSIS). Forty participants with local PSIS-related low back pain will be recruited and randomly assigned into two groups using the block balanced randomization method. The treatment group will receive CTDN targeting connective tissue trigger points around the PSIS in addition to a sacroiliac joint stabilization exercise program, while the control group will perform the same exercise program alone under the supervision of a physiotherapist. The intervention protocol will span two weeks, during which participants will attend three treatment sessions per week, for a total of six sessions. The primary outcome measurement will use the Visual Analog Scale (VAS) to assess pain intensity. The study will measure secondary outcomes through lumbar range of motion (ROM) in flexion and extension and pressure pain threshold (PPT), and Roland-Morris Disability Questionnaire (RMDQ) functional disability and Short Form-36 (SF-36) health-related quality of life. The researchers will assess all outcomes at three time points: baseline and after the first session, and the sixth session, while VAS will receive an additional assessment at the 3-month follow-up. The findings of this study are expected to provide evidence supporting CTDN as a safe, effective, and cost-efficient treatment option for PSIS-related mechanical low back pain.",[248,28,249],"Chronic Low Back Pain (CLBP)","Mechanical Low Back Pain",[249,28,251,252,253],"Connective Tissue Disorders","Dry Needling","Fascia \u002F Fascial Manipulation","2026-01-18",{"date":256,"type":39},"2026-01-21",{"date":258,"type":21},"2026-04-10",{"date":260,"type":21},"2026-09-01",{"name":181,"class":104},{"id":263,"slug":264,"hasResults":11,"nctId":265,"briefTitle":266,"officialTitle":266,"acronym":4,"eligibilityCriteria":267,"healthyVolunteers":11,"sex":17,"minAge":241,"maxAge":268,"enrollmentInfo":269,"targetDuration":4,"studyType":84,"phases":270,"briefSummary":271,"conditions":272,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":273,"lastUpdatePostDateStruct":274,"startDateStruct":276,"completionDateStruct":278,"leadSponsor":280,"locationsCount":70},"100606485","effects-of-innominate-rotation-correction-compared-with-sacral-torsion-correction-in-patients-with-sacroiliac-joint-dysfunction-100606485","NCT07176169","Effects of Innominate Rotation Correction Compared With Sacral Torsion Correction in Patients With Sacroiliac Joint Dysfunction","Inclusion Criteria:\n\n* Dysfunction based on at least 3 of the following tests\n\n  * Distraction Test\n  * Compression Test\n  * Gaenslen's Test\n  * Thigh Thrust Test\n  * Sacral Thrust Test\n\n    * Presence of Pain in Buttock, Posterior Pelvis, or Lower Lumbar Region for more than 2 weeks\n    * Confirmed Pelvic Asymmetry through Palpation (i.e., ASIS\u002FPSIS Landmarks, Gillet's Test)\n\nExclusion Criteria:\n\n* • History of Lumbar or Pelvic Fracture, Recent Surgery, or Hip\u002FKnee Pathology affecting Gait\u002FPosture.\n\n  * Pregnancy or Post-partum less than 6 months - due to Hormonal Laxity \\& Altered Biomechanics\n  * Systemic Inflammatory conditions - Rheumatoid Arthritis, Ankylosing Spondylitis\n  * Neurological Deficits - Cauda Equina Syndrome, Radiculopathy with Motor Loss\n  * Ongoing Physiotherapy treatment for Low Back Pain in past 4 weeks\n  * Inability\u002FContraindications to tolerate Manual Therapy - Osteoporosis\n  * Leg Length Discrepancy - \\>1.5 cm or Structural Scoliosis\n  * BMI \\> 35 (ASIA) - it may affect assessment validity due to obesity","50 Years",{"count":83,"type":21},[86],"The purpose of this study is to evaluate the comparative effects of Innominate Rotation Correction and Sacral Torsion Correction using Muscle Energy Techniques (METs) in patients with Sacroiliac Joint Dysfunction (SIJD). A total of 50 participants will be recruited, aged 18-50 yrs, with confirmed SIJD based on atleast 3 positive provocation tests. Participants will be randomized into two equal groups. Group A (Innominate Rotation Correction) and Group B (Sacral Torsion Correction). Both groups will receive Conventional Therapy (Thermotherapy, Electrotherapy and Core stabilization exercises).\n\nStudy variables include:\n\n* Independent Variable: Type of MET applied (Innominate vs Sacral Torsion)\n* Dependent Variables: Pain (measured by Visual Analog Scale), Functional Disability (assessed via Denver SIJ Disability Questionnaire)\n* Control Variables: Age, Gender, BMI, Baseline Pain\u002F Disability Scores\n\nThe intervention will last 4 weeks with 8 sessions (2 sessions per week). Assessments will be conducted at baseline (Week 1, Pre-treatment) and Post every second session. Data will be analyzed to compare immediate and short-term effects of the two interventions.\n\nThis study aims to provide evidence for targeted manual therapy approaches in SIJD, potentially guiding clinicians toward the most effective technique for pain reduction and functional improvement.",[28],"2025-12-26",{"date":275,"type":39},"2026-01-02",{"date":277,"type":21},"2025-12-30",{"date":279,"type":21},"2026-06-01",{"name":153,"class":104},{"id":282,"slug":283,"hasResults":11,"nctId":284,"briefTitle":285,"officialTitle":286,"acronym":4,"eligibilityCriteria":287,"healthyVolunteers":11,"sex":17,"minAge":216,"maxAge":268,"enrollmentInfo":288,"targetDuration":4,"studyType":84,"phases":290,"briefSummary":291,"conditions":292,"keywords":293,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":298,"lastUpdatePostDateStruct":299,"startDateStruct":301,"completionDateStruct":303,"leadSponsor":305,"locationsCount":4},"100614107","effects-of-pelvic-floor-exercises-and-muscle-energy-techniques-on-pain-and-disability-in-sacroiliac-joint-dysfunction-100614107","NCT07275294","Effects of Pelvic Floor Exercises and Muscle Energy Techniques on Pain and Disability in Sacroiliac Joint Dysfunction","Combined Effects of Pelvic Floor Exercises and Muscle Energy Techniques on Pain and Functional Disability in Patients With Sacroiliac Joint Dysfunction: A Randomized Controlled Trial","Inclusion Criteria\n\n* Unilateral sacroiliac joint dysfunction pre diagnosed patients\n* Both male and female\n* Age 30 to 50 years\n* Positive on at-least 3\u002F5 provocation tests (Compression, Distraction, Gaenslen, Thigh Thrust, Sacral Thrust and FABER (Flexion, Abduction, External Rotation) test)\n* Pain at Fortin area\n* Symptoms \\>3 weeks\n\nExclusion Criteria:\n\n* Pregnant females\n* Any other neurological, orthopedic, or musculoskeletal disorder\n* Recent history of pelvic surgery or any history of malignancy\n* Lumbar pathologies (scoliosis, spondylosis, spondylolisthesis)\n* Sacroiliitis",{"count":289,"type":21},46,[86],"This clinical trial aims to evaluate whether combining pelvic floor exercises with muscle energy techniques provides greater improvement in pain and functional disability in adults with sacroiliac joint dysfunction compared to muscle energy techniques alone. The study examines whether the addition of pelvic floor training enhances pain reduction and functional outcomes beyond the effects of muscle energy techniques applied to the hamstrings, gluteus medius, piriformis, and iliopsoas muscles. Participants will be assigned to either an experimental group receiving both pelvic floor exercises and muscle energy techniques or a control group receiving muscle energy techniques only, and will complete standardized assessments of pain and disability before and after the intervention.",[28],[294,295,296,297,169],"Pain","Functional Disability","Pelvic floor exercises","Muscle energy techniques","2025-12-08",{"date":300,"type":39},"2025-12-10",{"date":302,"type":21},"2025-12",{"date":304,"type":21},"2026-02",{"name":131,"class":104},{"id":307,"slug":308,"hasResults":11,"nctId":309,"briefTitle":310,"officialTitle":311,"acronym":4,"eligibilityCriteria":312,"healthyVolunteers":11,"sex":17,"minAge":241,"maxAge":313,"enrollmentInfo":314,"targetDuration":4,"studyType":84,"phases":316,"briefSummary":318,"conditions":319,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":321,"lastUpdatePostDateStruct":322,"startDateStruct":324,"completionDateStruct":326,"leadSponsor":328,"locationsCount":70},"100536736","phase-4-particulate-vs-non-particulate-steroid-for-sacroiliac-joint-injection-100536736","NCT06268704","Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection","Particulate Versus Non-Particulate Corticosteroid in Sacroiliac Joint Injection: A Randomized Prospective Study","Inclusion Criteria:\n\n* Aged \\>18, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits\n* Unilateral low back\u002Fbuttocks pain of at least 2 weeks.\n* Patient reported 7 day average of numeric pain rating score (NPRS) low back\u002Fbuttocks pain of at least 5\u002F10 at baseline evaluation\n* Clinical diagnosis of sacroiliac joint pain as diagnosed by a board certified Physiatrist including history of low back\u002Fbuttocks pain and at least 2 positive physical exam findings (including positive fortin finger sign, pain with palpation of posterior superior iliac spine, positive FABER's test, positive Gaenslan's test, positive sacral distraction, positive thigh thrust, positive lateral compression, positive sacral thrust)\n* Patient consents to sacroiliac joint corticosteroid injection in a shared decision-making process with the treating physician.\n* 80% or more relief of index pain within first 5-15 minutes after injection\n\nExclusion Criteria:\n\n* Clinical suspicion of alternative process is greater than clinical suspicion of sacroiliac joint pain\n* Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).\n* Those involved in active litigation relevant to their pain.\n* Those unable to read English and complete the assessment instruments.\n* Those unable to attend follow up appointments\n* The patient is incarcerated.\n* History of prior sacroiliac joint fusion\n* Progressive lower extremity neurologic deficit (from active radiculopathy, unhealed radiculopathy, or neuromuscular disease)\n* Sacroiliac joint steroid injection within the prior 12 months\n* 2 Positive lumbar medial branch blocks within the past 12 months\n* Radiofrequency ablation of the lumbar spine within the past 12 months\n* Lumbar facet steroid injections within the past 12 months\n* Prior epidural steroid injection within the prior 3 months in any location within the spine.\n* Possible pregnancy or other reason that precludes the use of fluoroscopy.\n* Allergy to steroid, contrast media, or local anesthetics.\n* BMI\\>40.\n* Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).\n* Active infection or treatment of infection with antibiotics within the past 7 days.\n* Medical conditions causing significant functional disability (e.g., stroke, decompensated ---COPD, decompensated heart failure)\n* Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).\n* Addictive behavior, severe clinical depression, or psychotic features.","99 Years",{"count":315,"type":21},230,[317],"PHASE4","This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.",[28,320],"Sacro-Iliac Spondylosis","2025-11-04",{"date":323,"type":39},"2025-11-06",{"date":325,"type":39},"2024-03-27",{"date":327,"type":21},"2027-05-01",{"name":329,"class":104},"University of New Mexico",{"id":331,"slug":332,"hasResults":11,"nctId":333,"briefTitle":334,"officialTitle":334,"acronym":4,"eligibilityCriteria":335,"healthyVolunteers":11,"sex":79,"minAge":336,"maxAge":216,"enrollmentInfo":337,"targetDuration":4,"studyType":84,"phases":339,"briefSummary":340,"conditions":341,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":342,"lastUpdatePostDateStruct":343,"startDateStruct":345,"completionDateStruct":347,"leadSponsor":349,"locationsCount":70},"100579171","effect-of-high-power-pain-threshold-ultrasound-on-postnatal-sacroiliac-joint-pain-100579171","NCT06820827","Effect of High Power Pain Threshold Ultrasound on Postnatal Sacroiliac Joint Pain","Inclusion Criteria:\n\n* Postpartum women diagnosed with sacroiliac joint pain and referred by an orthopedist.\n* Their ages will range from 20 to 30 years old.\n* Their body mass index (BMI) will range from 25 to 29.9 kg\u002Fm2.\n* All of them should have symptoms for at least two weeks postnatal\n\nExclusion Criteria:\n\n* Kidney diseases like stones or renal failure\n* History of ischemic heart diseases or Myocardial infarction\n* Severe vitamin D3 deficiency\n* Severe liver diseases or hepatitis\n* Psychological distress","20 Years",{"count":338,"type":21},28,[86],"This study will be conducted to investigate the effect of high-power pain threshold ultrasound on postnatal sacroiliac joint pain.",[28],"2025-02-13",{"date":344,"type":39},"2025-02-17",{"date":346,"type":21},"2025-02-12",{"date":348,"type":21},"2025-06-30",{"name":350,"class":104},"Cairo University",{"id":352,"slug":353,"hasResults":11,"nctId":354,"briefTitle":355,"officialTitle":356,"acronym":4,"eligibilityCriteria":357,"healthyVolunteers":11,"sex":17,"minAge":336,"maxAge":242,"enrollmentInfo":358,"targetDuration":4,"studyType":84,"phases":360,"briefSummary":361,"conditions":362,"keywords":363,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":367,"lastUpdatePostDateStruct":368,"startDateStruct":370,"completionDateStruct":372,"leadSponsor":374,"locationsCount":4},"100574629","combined-corticosteroid-injections-and-shockwave-therapy-for-sacroiliac-joint-pain-100574629","NCT06761768","Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain","Efficacy of Combining Corticosteroid Injections and Extracorporeal Shockwave Therapy in Patients With Sacroiliac Joint Pain","Inclusion Criteria:\n\n* Low back pain lasting for 3 months or more\n* Pain VAS score of 4 or higher\n* Three or more positive results in sacroiliac joint provocation tests\n* At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic\n\nExclusion Criteria:\n\n* Currently undergoing extracorporeal shockwave therapy in other areas\n* Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis\u002Fdisc degeneration, hip arthritis)\n* Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression\n* Sacroiliac joint injection therapy received within the past 6 months\n* Contraindications for extracorporeal shockwave therapy (e.g., cancer or current\u002Fprior infections at the treatment site, pacemakers, pregnancy, epilepsy, or coagulation disorders caused by disease or medication)\n* Impaired renal function preventing the administration of contrast agents for sacroiliac joint bone scanning",{"count":359,"type":21},44,[86],"This study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain.",[28,59],[28,364,365,366],"Sacroiliac joint pain","Steroid Injection","Extracorporeal shock wave therapy","2025-01-07",{"date":369,"type":39},"2025-01-09",{"date":371,"type":21},"2025-08-01",{"date":373,"type":21},"2026-07-31",{"name":375,"class":104},"Tri-Service General Hospital",{"id":377,"slug":378,"hasResults":11,"nctId":379,"briefTitle":380,"officialTitle":381,"acronym":382,"eligibilityCriteria":383,"healthyVolunteers":11,"sex":17,"minAge":241,"maxAge":4,"enrollmentInfo":384,"targetDuration":385,"studyType":22,"phases":4,"briefSummary":386,"conditions":387,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":388,"lastUpdatePostDateStruct":389,"startDateStruct":391,"completionDateStruct":393,"leadSponsor":395,"locationsCount":70},"100553580","real-world-registry-study-on-patient-satisfaction-with-transloc-3d-si-joint-fusion-100553580","NCT06487936","Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion","A Multi-Center, Real World Prospective\u002FRetrospective Registry to Evaluate Patient Satisfaction With the TransLoc 3D SI Joint Fusion System","RELIEF","Inclusion Criteria:\n\n* Age 18 year or older\n* Confirmed Implant of the Transloc 3D Fusion System\n* Did not have Transloc device removed or another manufacturer device implanted post Transloc\n* Does not have other manufacturer's titanium or metal implant\n* Patient may be included with prior allograft implant\n* Willing to participate and give written consent\n* Must have or planned CT post ≥1 year per standard of care\n\nExclusion Criteria:\n\n* Patient is younger than 18 years\n* Patient is unable to sign the Informed Consent\n* Implant of other manufacturer's titanium or alternative metal implant\n* Revision with another manufacturer's implant\n* Fracture or unresolved trauma of implant side after implantation of TransLoc\n* Patient unwilling to participate in Patient Satisfaction Survey\n* Patient has not returned for Standard of Care follow-up",{"count":20,"type":21},"18 Months","This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.",[28,196],"2024-08-21",{"date":390,"type":39},"2024-08-23",{"date":392,"type":39},"2024-08-15",{"date":394,"type":21},"2024-12-15",{"name":396,"class":46},"CornerLoc",{"id":398,"slug":399,"hasResults":11,"nctId":400,"briefTitle":401,"officialTitle":401,"acronym":4,"eligibilityCriteria":402,"healthyVolunteers":11,"sex":17,"minAge":336,"maxAge":161,"enrollmentInfo":403,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":404,"conditions":405,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":408,"lastUpdatePostDateStruct":409,"startDateStruct":411,"completionDateStruct":413,"leadSponsor":415,"locationsCount":70},"100550058","the-effect-of-bmi-on-gluteus-maximum-activity-in-adulthood-with-sacroiliac-dysfunction-100550058","NCT06442124","The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction","Inclusion Criteria:\n\n\\- adulthood with sacroiliac dysfunction\n\n* Their ages will range from 20-40 years old.\n* Their BMI will be less than 20- 30kg\u002Fm2.\n* All of them suffer from mild to moderate degree of sacroiliac pain.\n* The subjects complain from sacroiliac pain for 1 month ago\n\nExclusion Criteria:\n\n* Exclusion criteria were a history of any of the following condition:\n\n  * inflammatory diseases or any rheumatic disorders,\n  * a history of vertebral fractures\n  * surgical spinal fixation.\n  * •any neurological disorders like MS",{"count":164,"type":21},"PURPOSE:\n\nThis study will be conducted to investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction BACKGROUND: Sacroiliac joint (SIJ) pain is pain arising from SIJ structures and SIJ dysfunction (SIJD) generally refers to aberrant position or movement of SIJ structures . An estimated 15-30% of all low back pain cases are due to SIJ pain The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction\n\nHYPOTHESES:\n\n. •There will be no effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction\n\nRESEARCH QUESTION:\n\n* Do BMI has an effect on gluteus maximum activity in adulthood with sacroiliac dysfunction?",[28,406,407],"Obesity","EMG","2024-06-02",{"date":410,"type":39},"2024-06-04",{"date":412,"type":39},"2024-05-12",{"date":414,"type":21},"2024-06-30",{"name":416,"class":104},"Ahram Canadian University"]